Table 1.
Summary of the clinical data and MRI and MRS findings for cerebellar hemangioblastomas.
| Case | Age/sex | Clinical presentation | Ope | VHL findings | IH | Conventional MRI findings | ADC map/ADC value (10−3 mm2/s) | rCBV map/rCBV ratio | Lip-lac | Cho NAACr |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 35/F | ・Headache | TR | Negative | Inhibin-α D2-40 | Cyst with nodule with FV | Increased/1.6 | Increased/12.42 | NA | NA |
| NA | ||||||||||
| NA | ||||||||||
| 2 | 32/F | ・Headache | TR | Negative | Inhibin-α S100 | Solid nodule without FV | Increased/1.3 | Increased/NA | + | + |
| ・Dizziness | + | |||||||||
| ・Sensory disorders | + | |||||||||
| 3 | 84/M | ・Dysarthria | TR | Negative | Inhibin-α S100 | Solid mass with FV | Increased/2.3 | Increased/12.27 | ++ | – |
| ・Lightheadedness | – | |||||||||
| – |
MRI: magnetic resonance imaging; MRS: magnetic resonance spectroscopy; Ope: operation; VHL: Von Hippel–Lindau disease; IH: positive immunohistochemistry tests for stromal cells; ADC: apparent diffusion coefficiency; rCBV: relative cerebral volume; Lip-Lac: lipid and/or lactate; Cho: choline; NAA: N-acetylaspartate; Cr: creatine; FV: flow void; TR: total resection; NA: not available; +: present; ++: elevated; –: absent.